What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Surgery
Internal medicine, Surgery, Gastroenterology, Immunology and Pathology are his primary areas of study.
His work on Internal medicine deals in particular with Pulmonary hypertension, Prospective cohort study, Pulmonary function testing, Connective tissue disease and Randomized controlled trial.
His studies deal with areas such as Incidence, Cohort and DLCO as well as Surgery.
His Gastroenterology study combines topics in areas such as Anemia, Lymphoma and Interstitial lung disease.
The concepts of his Immunology study are interwoven with issues in Odds ratio, Single-nucleotide polymorphism and Allele.
His study in Pathology is interdisciplinary in nature, drawing from both Myeloid, Autoantibody, Lung and B cell.
His most cited work include:
- Pulmonary arterial hypertension in France: results from a national registry. (1450 citations)
- Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients (1443 citations)
- Survival in Patients With Idiopathic, Familial, and Anorexigen-Associated Pulmonary Arterial Hypertension in the Modern Management Era (1075 citations)
What are the main themes of his work throughout his whole career to date?
Eric Hachulla focuses on Internal medicine, Immunology, Surgery, Gastroenterology and Pathology.
His study explores the link between Internal medicine and topics such as Cardiology that cross with problems in Associated Pulmonary Arterial Hypertension.
His Immunology research is multidisciplinary, incorporating elements of Single-nucleotide polymorphism, Genotype and Allele.
Eric Hachulla combines subjects such as Adverse effect and Connective tissue disease with his study of Surgery.
His Gastroenterology research incorporates themes from Autoantibody, Vasculitis and Rituximab.
His work on Biopsy as part of general Pathology study is frequently linked to In patient, therefore connecting diverse disciplines of science.
He most often published in these fields:
- Internal medicine (51.59%)
- Immunology (18.47%)
- Surgery (17.62%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (51.59%)
- Cohort (11.04%)
- Interstitial lung disease (9.98%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Internal medicine, Cohort, Interstitial lung disease, Disease and Gastroenterology.
His Internal medicine research focuses on subjects like Autoantibody, which are linked to Dermatomyositis.
The study incorporates disciplines such as Systemic scleroderma, Pulmonary hypertension, Mean age and Myositis in addition to Cohort.
His research in Interstitial lung disease intersects with topics in Lung fibrosis and FEV1/FVC ratio.
His study on Disease also encompasses disciplines like
- Epidemiology together with Pediatrics,
- Intensive care medicine, which have a strong connection to Rheumatism.
The Gastroenterology study which covers Vasculitis that intersects with Eosinophilic.
Between 2018 and 2021, his most popular works were:
- Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study (61 citations)
- Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosis (42 citations)
- Systemic lupus erythematosus: state of the art on clinical practice guidelines. (31 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Cancer
His primary scientific interests are in Internal medicine, Disease, Intensive care medicine, Cohort and Scleroderma.
His research links Placebo with Internal medicine.
Eric Hachulla works mostly in the field of Disease, limiting it down to topics relating to Epidemiology and, in certain cases, Comorbidity, Pediatrics, Giant cell arteritis and National health insurance, as a part of the same area of interest.
His Cohort research integrates issues from Gastroenterology, Autoantibody and Psychological intervention.
His studies deal with areas such as Odds ratio, Pulmonary hypertension, Systemic scleroderma, Hazard ratio and Diffusing capacity as well as Gastroenterology.
His Scleroderma research is multidisciplinary, relying on both Rheumatism and Prospective cohort study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
